期刊文献+

肥厚型梗阻性心肌病化学消融术后的疗效分析

下载PDF
导出
摘要 肥厚型心肌病以心肌肥厚、心室腔缩小为特征,以左室血流充盈受阻、舒张期顺应性下降为基本病变。肥厚型心肌病的主要症状包括呼吸困难、胸痛、心律失常、晕厥、猝死等,发病率约为0.2%。约70%的肥厚型心肌病患者存在流出道梗阻,当左室与主动脉流出道之间压差〉50mmHg时,有手术指征。
出处 《国际心血管病杂志》 2015年第6期426-428,共3页 International Journal of Cardiovascular Disease
基金 国家自然科学基金面上项目(81370266)
  • 相关文献

参考文献8

  • 1Maron BJ, Maron MS. Hypertrophic cardiomyopathy [J ]. Lancet, 2013,381 (9862) : 242-255.
  • 2Desai MY, Bhonsale A, Smedira NG,et al. Predictors of long- term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction[J]. Circulation, 2013,128 (3) :209-216.
  • 3Maron BJ, Nishimura RA. Surgical septal myectomy versus alcohol septal ablation., assessing the status of the controversy in 2014[J]. Circulation,2014,130(18) : 1617-1624.
  • 4Maron BJ, Nishimura RA, McKenna WJ,et al. Assessment of permanent dual-chamber pacing as a treatment for drug refractory symptomatic patients with obstructive hypertrophic eardiomyopathy. A randomized, double-blind, crossover study (M-PATHY) [J], Circulation, 1999,99(22) : 2927-2933.
  • 5Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy= executive summary= a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. J Am Coil Cardiol, 2011,58(25) =2703-2738.
  • 6Steggerda RC, Damman K, Bait JC, et al. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myeetomy in hypertrophic obstructive cardiomyopathy: a single-center experience E J 1. JACC Cardiovasc Interv, 2014,7 ( 11 ) : 1227-1234.
  • 7Yoerger DM, Picard MH, Palacios IF, et al. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy[-J]. Am J Cardiol, 2006,97(10) ; 1511-1514.
  • 8葛均波,崔洁.无创检查在肥厚型心肌病诊断中的应用[J].国际心血管病杂志,2011,38(1):5-8. 被引量:10

二级参考文献7

  • 1Maron BJ, McKenna WJ. Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines[J]. Eur Heart J,2003,24(21): 1965-1091.
  • 2Harris KM, Spirito P, Maron MS, et al. Prevalence.clinical profile,and significance of left vemrieular remodeling in the end stage phase of hypertrophic cardiomyopathy [ J ]. Circulation,2006,114(3) :216-225.
  • 3Maron MS, Olivotto I, Zenovieh AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction[J].Circulation, 2006, 114(21) 2232- 2239.
  • 4Lee CH, Liu PY, Lin I.J, et al. Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan[J]. Cardiology,2006,106(1 ) :29 -35.
  • 5Cecchi F, Olivotto I, Gistrl R. el al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J].N Engl J Med. 2003, 349(11):1027- 1035.
  • 6Pieroni M, Bellocci F, Sanna T, et al. Increased brain natriuretlc peptide secretion is a marker of disease progression in nonobstmetive hypertrophic cardiomyopathy[J]. J Card Fail, 2007,13(5) :380 -388.
  • 7陈海燕,舒先红,潘翠珍,程蕾蕾,董丽莉,崔洁.应用速度向量显像技术评价正常人及肥厚型心肌病患者的心肌扭转[J].中华超声影像学杂志,2008,17(3):193-195. 被引量:6

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部